$5.74
-0.17-2.88%
At close: -
$5.74
0.000.00%
After Hours: Dec 27, 4:00 PM EDT
Voyager Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Voyager Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $-0.16 | $-0.45 | 64.4 % |
Jun 2024 | 2024-08-06 | $-0.18 | $-0.41 | 56.1 % |
Mar 2024 | 2024-05-13 | $-0.20 | $-0.44 | 54.5 % |
Dec 2023 | 2024-02-28 | $1.25 | $-0.29 | 531.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $24.63M | $11.89M | 107.1 % |
Jun 2024 | 2024-08-06 | $29.58M | $9.46M | 212.7 % |
Mar 2024 | 2024-05-13 | $19.52M | $9.41M | 107.4 % |
Dec 2023 | 2024-02-28 | $90.06M | $20.63M | 336.6 % |
Voyager Therapeutics (VYGR) is scheduled to report earnings on February 26, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.16, which beat the estimate of $-0.45.
The Actual Revenue was $24.6M, which beat the estimate of $11.9M.
Browse earnings estimates, EPS, and revenue on all stocks.